QuellTX
Siddharth Krishnan is an accomplished scientist with extensive experience in the fields of analytical development and neuroscience. Currently serving as an Associate Senior Scientist and Analytical Development Scientist at Cell and Gene Therapy Catapult since April 2021, Siddharth previously held the position of Postdoctoral Research Associate at The University of Manchester from January 2015 to April 2021, contributing to research on immune-mediated pathways in stroke patients and the mononuclear phagocyte network in the oral barrier. Additional roles include Graduate Teaching Assistant and Social Media Editor for the Journal of Cerebral Blood Flow and Metabolism. Siddharth's early experience includes a Biomedical Research Internship at Mayo Clinic, focusing on Alzheimer's disease, and an internship at Orchid Pharma in drug discovery. Siddharth holds a Bachelor of Science (Hons.) in Pharmacology with Industrial Experience and a PhD in Neuroscience, both obtained from The University of Manchester.
This person is not in the org chart
This person is not in any teams
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.